Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design

por Klaassen-Dekker, A., Drossaert, C. H. C., Van Maaren, M. C., Van Leeuwen-Stok, A. E., Retel, V. P., Korevaar, J. C., Siesling, S.
Publicado 2023

Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer

por Moossdorff, M., Vane, Marissa L. G., van Nijnatten, T. J. A., van Maaren, M. C., Goorts, B., Heuts, E. M., Strobbe, L. J. A., Smidt, M. L.
Publicado 2021

Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA

por Ragusi, M. A. A., van der Velden, B. H. M., van Maaren, M. C., van der Wall, E., van Gils, C. H., Pijnappel, R. M., Gilhuijs, K. G. A., Elias, S. G.
Publicado 2022

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer

por van Uden, D. J. P., van Maaren, M. C., Strobbe, L. J. A., Bult, P., van der Hoeven, J. J., Siesling, S., de Wilt, J. H. W., Blanken-Peeters, C. F. J. M.
Publicado 2019